Btk and phospholipase Cγ2 can function independently during B cell development

European Journal of Immunology

Volumn 37, Issue 4, 2007, Pages 1033-1042

  Halcomb, Kristina E ^a   Contreras, Cristina M ^a   Hinman, Rochelle M ^a   Coursey, Terry G ^a   Wright, Heather L ^a   Satterthwaite, Anne B ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

B cell linker protein; ERK; Lymphoma; Pre B cell; Stromal cell derived factor 1

Indexed keywords

B LYMPHOCYTE RECEPTOR; BRUTON TYROSINE KINASE; IMMUNOGLOBULIN LAMBDA CHAIN; IMMUNOGLOBULIN M ANTIBODY; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOLIPASE C GAMMA2; STROMAL CELL DERIVED FACTOR 1; AGAMMAGLOBULINAEMIA TYROSINE KINASE; ISOENZYME; PHOSPHOLIPASE C GAMMA; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL MATURATION; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; CROSS LINKING; FREQUENCY ANALYSIS; LYMPHOCYTE MIGRATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SPLEEN CELL; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; COMPARATIVE STUDY; CYTOLOGY; ENZYMOLOGY; GENETICS; IMMUNOLOGY; MOUSE MUTANT; PHYSIOLOGY;

ANIMALS; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; ISOENZYMES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHOSPHOLIPASE C GAMMA; PROTEIN-TYROSINE KINASES;

EID: 34249670327     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200636451     Document Type: Article

References (62)

1. Rolink, A. G., Schaniel, C., Andersson, J. and Melchers, F., Selection events operating at various stages in B cell development. Curr. Opin. Immunol. 2001. 13: 202-207.
2. Fruman, D. A., Satterthwaite, A. B. and Witte, O. N., Xid-like phenotypes: A B cell signalosome takes shape. Immunity 2000. 13: 1-3.
3. Kurosaki, T. and Tsukada, S., BLNK: Connecting Syk and Btk to calcium signals. Immunity 2000. 12: 1-5.
4. Guo, B., Kato, R. M., Garcia-Lloret, M., Wahl, M. I. and Rawlings, D. J., Engagement of the human pre-B cell receptor generates a lipid raft-dependent calcium signaling complex. Immunity 2000. 13: 243-253.
5. Saito, K., Tolias, K. F., Saci, A., Koon, H. B., Humphries, L. A., Scharenberg, A., Rawlings, D. J. et al., BTK regulates PtdIns-4,5-P2 synthesis: Importance for calcium signaling and PI3K activity. Immunity 2003. 19: 669-678.
6. Middendorp, S., Dingjan, G. M., Maas, A., Dahlenborg, K. and Hendriks, R. W., Function of Bruton's tyrosine kinase during B cell development is partially independent of its catalytic activity. J. Immunol. 2003. 171: 5988-5996.
7. Tsukada, S., Saffran, D. C., Rawlings, D. J., Parolini, O., Allen, R. C., Klisak, I, Sparkes, R. S. et al., Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. cell 1993. 72: 279-290.
8. Vetrie, D., Vorechovsky, I, Sideras, P., Holland, J., Davies, A., Flinter, F., Hammarstrom, L. et al., The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature 1993. 361: 226-233.
9. Minegishi, Y., Rohrer, J., Coustan-Smith, E., Lederman, H. M., Pappu, R., Campana, D., Chan, A. C. and Conley, M. E., An essential role for BLNK in human B cell development. Science 1999. 286: 1954-1957.
10. Khan, W. N., Alt, F. W., Gerstein, R. M., Malynn, B. A., Larsson, I, Rathbun, G., Davidson, L. et al., Defective B cell development and function in Btk-deficient mice. Immunity 1995. 3: 283-299.
11. Kerner, J. D., Appleby, M. W., Mohr, R. N., Chien, S., Rawlings, D. J., Maliszewski, C. R., Witte, O. N. and Perlmutter, R. M., Impaired expansion of mouse B cell progenitors lacking Btk. Immunity 1995. 3: 301-312.
12. Hendriks, R. W., de Bruijn, M. F., Maas, A., Dingjan, G. M., Karis, A. and Grosveld, F., Inactivation of Btk by insertion of lacZ reveals defects in B cell development only past the pre-B cell stage. EMBO J. 1996. 15: 4862-4872.
13. Pappu, R., Cheng, A. M., Li, B., Gong, Q., Chin, C., Griffin, N., White, M. et al., Requirement for B cell linker protein (BLNK) in B cell development. Science 1999. 286: 1949-1954.
14. Jumaa, H., Wollscheid, B., Mitterer, M., Wienands, J., Reth, M. and Nielsen, P. J., Abnormal development and function of B lymphocytes in mice deficient for the signaling adaptor protein SLP-65. Immunity 1999. 11: 547-554.
15. Hayashi, K., Nittono, R., Okamoto, N., Tsuji, S., Hara, Y., Goitsuka, R. and Kitamura, D., The B cell-restricted adaptor BASH is required for normal development and antigen receptor-mediated activation of B cells. Proc. Natl. Acad. Sci. USA 2000. 97: 2755-2760.
16. Xu, S., Tan, J. E., Wong, E. P., Manickam, A., Ponniah, S. and Lam, K. P., B cell development and activation defects resulting in xid-like immunodeficiency in BLNK/SLP-65-deficient mice. Int. Immunol. 2000. 12: 397-404.
17. Wang, D., Feng, J., Wen, R., Marine, J. C., Sangster, M. Y., Parganas, E., Hoffmeyer, A. et al., Phospholipase Cgamma2 is essential in the functions of B cell and several Fc receptors. Immunity 2000. 13: 25-35.
18. Hashimoto, A., Takeda, K., Inaba, M., Sekimata, M., Kaisho, T., Ikehara, S., Homma, Y. et al., Cutting edge: Essential role of phospholipase C-gamma 2 in B cell development and function. J. Immunol. 2000. 165: 1738-1742.
19. Dingjan, G. M., Middendorp, S., Dahlenborg, K., Maas, A., Grosveld, F. and Hendriks, R. W., Bruton's tyrosine kinase regulates the activation of gene rearrangements at the lambda light chain locus in precursor B cells in the mouse. J. Exp. Med. 2001. 193: 1169-1178.
20. Middendorp, S., Dingjan, G. M. and Hendriks, R. W., impaired precursor B cell differentiation in Bruton's tyrosine kinase-deficient mice. J. Immunol. 2002. 168: 2695-2703.
21. Flemming, A., Brummer, T., Reth, M. and Jumaa, H., The adaptor protein SLP-65 acts as a tumor suppressor that limits pre-B cell expansion. Nat. Immunol. 2003. 4: 38-43.
22. Jumaa, H., Mitterer, M., Reth, M. and Nielsen, P. J., The absence of SLP65 and Btk blocks B cell development at the preB cell receptor-positive stage. Eur. J. Immunol. 2001. 31: 2164-2169.
23. Kersseboom, R., Middendorp, S., Dingjan, G. M., Dahlenborg, K., Reth, M., Jumaa, H. and Hendriks, R. W., Bruton's tyrosine kinase cooperates with the B cell linker protein SLP-65 as a tumor suppressor in pre-B cells. J. Exp. Med. 2003. 198: 91-98.
24. Hayashi, K., Yamamoto, M., Nojima, T., Goitsuka, R. and Kitamura D., Distinct signaling requirements for Dmu selection, IgH allelic exclusion, pre-B cell transition, and tumor suppression in B cell progenitors. Immunity 2003. 18: 825-836.
25. Su, Y. and Jumaa, H., LAT links the pre-BCR to calcium signaling. Immunity 2003. 19: 295-305.
26. Watanabe, D., Hashimoto, S., Ishiai, M., Matsushita, M., Baba, Y., Kishimoto, T., Kurosaki, T. and Tsukada, S., Four tyrosine residues in phospholipase C-gamma 2, identified as Btk-dependent phosphorylation sites, are required for B cell antigen receptor-coupled calcium signaling. J. Biol. Chem. 2001. 276: 38595-38601.
27. Humphries, L. A., Dangelmaier, C., Sommer, K., Kipp, K., Kato, R. M., Griffith, N., Bakman, I. et al., Tee kinases mediate sustained calcium influx via site-specific tyrosine phosphorylation of the phospholipase Cgamma src homology 2-src homology 3 linker. J. Biol. Chem. 2004. 279: 37651-37661.
28. Forsell, J., Nilsson, A. and Sideras, P., Reduced formation of phosphatidic acid upon B-cell receptor triggering of mouse B-lymphocytes lacking Bruton's tyrosine kinase. Scand. J. Immunol. 2000. 52: 30-38.
29. Bell, S. E., Vigorito, E., McAdam, S., Reynolds, H. M., Caraux, A., Colucci, F. and Turner, M., PLCgamma2 regulates Bcl-2 levels and is required for survival rather than differentiation of marginal zone and follicular B cells. Eur. J. Immunol. 2004. 34: 2237-2247.
30. Middendorp, S., Zijlstra, A. J., Kersseboom, R., Dingjan, G. M., Jumaa, H. and Hendriks, R. W., Tumor suppressor function of Bruton's tyrosine kinase is independent of its catalytic activity. Blood 2005. 105: 259-265.
31. Xu, S., Huo, J., Chew, W. K., Hikida, M., Kurosaki, T. and Lam, K. P., Phospholipase Cgamma2 dosage is critical for B cell development in the absence of adaptor protein BLNK. J. Immunol. 2006. 176: 4690-4698.
32. von Freeden-Jeffry, U., Vieira, P., Lucian, L. A., McNeil, T., Burdach, S. E. and Murray, R., Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J. Exp. Med. 1995. 181:1519-1525.
33. Nagasawa, T., Hirota, S., Tachibana, K., Takakura, N., Nishikawa, S., Kitamura, Y., Yoshida, N. et al., Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 1996. 382: 635-638.
34. Fedyk, E. R., Ryyan, D. H., Ritterman, I. and Springer, T.A., Maturation decreases responsiveness of human bone marrow B lineage cells to stromal-derived factor 1 (SDF-1). J. Leukoc. Biol. 1999. 66: 667-673.
35. Fischer, A. M., Mercer, J. C., Iyer, A., Ragin, M. J. and August, A., Regulation of CXC chemokine receptor 4-mediated migration by the Tec family tyrosine kinase Itk. J. Biol. Chem. 2004. 279: 29816-29820.
36. Takesono, A., Horai, R., Mandai, M., Dombroski, D. and Schwartzberg, P. L., Requirement for Tec kinases in chemokine-induced migration and activation of Cdc42 and Rac. Curr. Biol. 2004. 14: 917-922.
37. Katagiri, K., Shimonaka, M. and Kinashi, T., Rap1-mediated lymphocyte function-associated antigen-1 activation by the T cell antigen receptor is dependent on phospholipase C-gamma1. J. Biol. Chem. 2004. 279: 11875-11881.
38. Atkinson, B. T., Ellmeier, W. and Watson, S. P., Tec regulates platelet activation by GPVI in the absence of Btk. Blood 2003. 102: 3592-3599.
39. Ellmeier, W., Jung, S., Sunshine, M. J., Hatam, F., Xu, Y., Baltimore, D., Mano, H. and Littman, D. R., Severe B cell deficiency in mice lacking the Tec kinase family members Tee and Btk. J. Exp. Med. 2000. 192: 1611-1624.
40. Wen, R., Chen, Y., Schuman, J., Fu, G., Yang, S., Zhang, W., Newman, D. K. and Wang, D., An important role of phospholipase Cgamma1 in pre-B-cell development and allelic exclusion. EMBO J. 2004. 23: 4007-4017.
41. Cory, G. O., Lovering, R. C., Hinshelwood, S., MacCarthy-Morrogh, L., Levinsky, R. J. and Kinnon, C., The protein product of the c-cbl protooncogene is phosphorylated after B cell receptor stimulation and binds the SH3 domain of Bruton's tyrosine kinase. J. Exp. Med. 1995. 182: 611-615.
42. Guinamard, R., Fougereau, M. and Seckinger, P., The SH3 domain of Bruton's tyrosine kinase interacts with Vav, Sam68 and EWS. Scand. J. Immunol. 1997. 45: 587-595.
43. Baba, Y, Nonoyama, S., Matsushita, M., Yamadori, T., Hashimoto, S., Imai, K., Arai, S. et al., Involvement of Wiskott-Aldrich syndrome protein in B-cell cytoplasmic tyrosine kinase pathway. Blood 1999. 93: 2003-2012.
44. Tsukada, S., Simon, M. I, Witte, O. N. and Katz, A., Binding of beta gamma subunits of heterotrimeric G proteins to the PH domain of Bruton tyrosine kinase. Proc. Natl. Acad. Sci. USA 1994. 91: 11256-11260.
45. Ma, Y. C. and Huang, X. Y., Identification of the binding site for Gqalpha on its effector Bruton's tyrosine kinase. Proc. Natl. Acad. Sci. USA 1998. 5: 12197-12201.
46. Kikuchi, Y., Hirano, M., Seto, M. and Takatsu, K., Identification and characterization of a molecule, BAM11, that associates with the pleckstrin homology domain of mouse Btk. Int. Immunol. 2000. 12: 1397-1408.
47. Yamadori, T., Baba, Y., Matsushita, M., Hashimoto, S., Kurosaki, M., Kurosaki, T., Kishimoto, T. and Tsukada, S., Bruton's tyrosine kinase activity is negatively regulated by Sab, the Btk-SH3 domain-binding protein. Proc. Natl. Acad. Sci. USA 1999. 96: 6341-6346.
48. Liu, W., Quinto, I., Chen, X., Palmieri, C., Rabin, R. L., Schwartz, O. M., Nelson, D. L. and Scala, G., Direct inhibition of Bruton's tyrosine kinase by IBtk, a Btk-binding protein. Nat. Immunol. 2001. 2: 939-946.
49. Novina, C. D., Kumar, S., Bajpai, U., Cheriyath, V., Zhang, K., Pillai, S., Wortis, H. H. and Roy, A. L., Regulation of nuclear localization and transcriptional activity of TFII-I by Bruton's tyrosine kinase. Mol. Cell. Biol. 1999. 19: 5014-5024.
50. Webb, C. F., Yamashita, Y., Ayers, N., Evetts, S., Paulin, Y., Conley, M. E. and Smith, E. A., The transcription factor Bright associates with Bruton's tyrosine kinase, the defective protein in immunodeficiency disease. J. Immunol. 2000. 165: 6956-6965.
51. Mahajan, S., Vassilev, A., Sun, N., Ozer, Z., Mao, C. and Uckun, F. M., Transcription factor STAT5A is a substrate of Bruton's tyrosine kinase in B cells. J. Biol. Chem. 2001. 276: 31216-31228.
52. Moreno-Garcia, M. E., Lopex-Bojorques, L. N., Zentella, A., Humphries, L. A., Rawlings, D. J. and Santos-Argumedo, L., CD38 signaling regulates B lymphocyte activation via a phospholipase C (PLC)-gamma 2-independent, protein kinase C, phosphatidylcholine-PLC, and phospholipase D-dependent signaling cascade. J. Immunol. 2005. 174: 2687-2695.
53. Hinman, R. M., Bushanam, J. N., Nichols, W. A. and Satterthwaite, A. B., B cell receptor signaling down-regulates forkhead box transcription factor class O 1 mRNA expression via phosphatidylinositiol 3-kinase and Bruton's tyrosine kinase. J. Immunol. 2007. 178: 732-739.
54. Schebesta, M., Pfeffer, P. L. and Busslinger, M., Control of pre-BCR signaling by Pax5-dependent activation of the BLNK gene. Immunity 2002. 17: 473-485.
55. Hoffmann, R., Seidl, T., Neeb, M., Rolink, A. and Melchers, F., Changes in gene expression profiles in developing B cells of routine bone marrow. Genome Res. 2002. 12: 98-111.
56. Nore, B. F., Vargas, L., Mohamed, A. J., Branden, L. J., Backesjo, C. M., Islam, T. C., Mattsson, P. T. et al., Redistribution of Bruton's tyrosine kinase by activation of phosphatidylinositol 3-kinase and Rho-family GTPases. Eur. Immunol. 2000. 30: 145-154.
57. Guinamard, R., Signoret, N., Ishiai, M., Marsh, M., Kurosaki, T., Ravetch, J. V. and Masamichi, I., B cell antigen receptor engagement inhibits stromal cell-derived factor (SDF)-1alpha chemotaxis and promotes protein kinase C (PKC)-induced internalization of CXCR4. J. Exp. Med. 1999. 189: 1461-1466.
58. Kim, C. H., Hangoc, G., Cooper, S., Helgason, C. D., Yew, S., Humphries, R. K., Krystal, G. and Broxmeyer, H. E., Altered responsiveness to chemokines due to targeted disruption of SHIP. J. Clin. Invest. 1999. 104: 1751-1759.
59. Scharenberg, A. M., El-Hillal, O., Fruman, D. A., Beitz, L. O., Li, Z., Lin, S., Gout, I. et al., Phosphatidylinositol-3,4,5-trisphosphate (PtdIns-3,4,5-P3)/Tec kinase-dependent calcium signaling pathway: A target for SHIP-mediated inhibitory signals. EMBO J. 1998. 17: 1961-1972.
60. Bolland, S., Pearse, R. N., Kurosaki, T. and Ravetch, J. V., SHIP modulates immune receptor responses by regulating membrane association of Btk. Immunity 1998. 8: 509-516.
61. Bykowsky, M. J., Haire, R. N., Ohta, Y., Tang, H., Sung, S. S., Veksler, E. S., Greene, J. M. et al., Discordant phenotype in siblings with X-linked agammaglobulinemia. Am. J. Hum. Genet. 1996. 58: 477-483.
62. Jumaa, H., Bossaller, L., Portugal, K., Storch, B., Lotz, M., Flemming, A., Schrappe, M. et al., Deficiency of the adaptor SLP-65 in pre-B-cell acute lymphoblastic leukaemia. Nature 2003. 423: 452-456.